DexCom Receives FDA Warning Letter for Administrative Deficiencies in its MDR Reporting

SAN DIEGO---- DexCom, Inc. announced today that it has received a warning letter from the U.S. Food& Drug Administration resulting from a November 2013 inspection of the Company' s facility in San Diego, California by the FDA' s Los Angeles District Office.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.